BioCentury
ARTICLE | Company News

Kirin to commercialize Inspire diagnostic

September 13, 2000 7:00 AM UTC

Kirin Brewery (Tokyo, Japan) acquired Asian rights to ISPH's INS316 diagnostic. ISPH said the initial indication for INS316 will be to aid in the diagnosis of lung cancer. The alliance combines ISPH's...